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ABSTRACT OF THE THESIS 
CELLULAR EVENTS UNDER FLOW STATES PERTINENT TO HEART 
VALVE FUNCTION 
by 
Glenda Castellanos  
Florida International University, 2015 
Miami, Florida 
Professor Sharan Ramaswamy, Major Professor 
Heart valve disease (HVD) or a damaged valve can severely compromise the 
heart's ability to pump efficiently. Balloon valvuloplasty is preferred on neonates with 
aortic valve stenosis. Even though this procedure decreases the gradient pressure across 
the aortic valve, restenosis is observed soon after balloon intervention. Tissue 
engineering heart valves (TEHV), using bone marrow stem cells (BMSCs) and 
biodegradable scaffolds, have been investigated as an alternative to current non-viable 
prosthesis. By observing the changes in hemodynamics following balloon aortic 
valvuloplasty, we could uncover a potential cause for rapid restenosis after balloon 
intervention. Subsequently, a tissue engineering treatment strategy based on BMSC 
mechanobiology could be defined. Understanding and identifying the mechanisms by 
which cytoskeletal changes may lead to cellular differentiation of a valvular phenotype is 
a first critical step in enhancing the promotion of a robust valvular phenotype from 
BMSCs. 
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CHAPTER 1: INTRODUCTION 
Valvular heart disease is a serious cardiovascular complication. Approximately 275000 
people in the United States undergo heart valve replacement every year; ~5000 are 
children1. Heart valves perform a critical role in maintaining unidirectional blood flow. 
The tissue and cells that constitute the leaflets must have unique characteristics that allow 
them to open and close properly, as well as remodel as needed2. The leaflets also 
experience complex mechanical stresses which their composition and structure allows 
them to endure3. They are comprised of three different layers, which include the fibrosa 
(facing the artery), ventricularis (facing the ventricle), and the spongiosa, which is 
located between the fibrosa and the ventricularis4. Similar to blood vessels, the surface of 
the heart valves are lined with endothelial cells, which have been known to have the 
ability to sense and respond to different mechanical and hemodynamic environments, and 
rapidly change their behavior2,3. However, in vitro studies have suggested that vascular 
and valvular endothelial cells are distinct in their response to hemodynamics2. 
Congenital heart defects are the most common birth defect, with about 1% of the 
population being affected by them4. Around 24.5% of neonatal mortality is due to 
congenital heart defects5, one of the most severe being critical aortic valve stenosis 
(AVS), a life-threatening condition with high morbidity despite early intervention. Open 
surgical valvotomy and a less invasive procedure, transcatheter balloon valvuloplasty of 
the aortic valve, are two of the most used and recognized procedures done TO neonates 
with AVS. Balloon valvuloplasty has been shown to reduce the pressure gradient across 
the aortic valve around 60%6. Even though this procedure has shown promising results, 
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reintervention following aortic balloon valvuloplasty is high due to several factors, 
including restenosis in one third of the patients6. Recent studies have shown that in 
vascular endothelial cells, flow patterns are critical in the sense that they influence the 
initiation of atherosclerosis, in-stent restenosis, and bypass graft failure. After balloon 
valvuloplasty, there is a relief in the pressure gradient across the aortic valve, however 
the hemodynamics do not resemble that of a normal valve, which could play an important 
role in the cause of restenosis. Valvular leaflet remodeling has been traced to endothelial 
cell dysfunction and denudation2, which is the primary suspect for the cause of restenosis 
in patients with balloon valvuloplasty. Valvular endothelial cells, like vascular 
endothelial cells, are known to remodel in response to hemodynamic environments by 
sensing the mechanical signals, and reorganizing the cytoskeletal filaments and the focal 
adhesion complexes2. The process by which valvular endothelial cells remodel after 
balloon intervention is not well known. By evaluating the changes in valvular endothelial 
cells’ intracellular structural proteins in response to flow profiles following balloon 
intervention, we can delineate potential abnormal responses, which could be linked to the 
underlying cause of rapid restenosis after balloon implantation.  
The need for reintervention after balloon valvuloplasty is very common, eventually 
leading to surgical valve repair or valve replacement. Tissue engineering heart valves 
(TEHVs), based on bone marrow stem cells (BMSCs) and biodegradable scaffolds, have 
been investigated as the next step to current prosthesis limitations, particularly the lack of 
somatic growth, which is critical in the pediatric patient population7. BMSCs are a 
promising cell source due to their accessibility and phenotypic plasticity under 
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biochemical and mechanical stimulation. TEHVs have shown a resemblance in the tri-
layer structure found in the heart valve; however structural differences such as the 
absence of surface ridges in TEHVs are evident and may contribute to the early failure of 
these constructs8. Recent studies have shown that shear stress can regulate the 
proliferation and differentiation of BMSCs through a variety of signaling pathways9. 
Heart valves experience mechanical stresses, including cyclic flexure, tensile, and fluid-
induced shear stress patterns, such as oscillatory shear stresses (OSS), during their 
lifetime10. It was previously demonstrated that coupled flexure and flow environments 
augmented tissue formation using PGA:PLLA scaffolds seeded with BMSCs11. At the 
intracellular scale, changes in BMSC cytoskeleton have also been observed when BMSCs 
were exposed to fluid induced shear stress. Alterations in F-actin structure and 
distribution may thus be closely linked to gene expression and protein synthesis in the 
mechanobiology of stem cells2. In addition, we believe that focal adhesion patterns are 
important to observe, as they sense mechanical forces and act as conduits for translating 
these physical forces into chemical and genetic cellular responses. OSS may also further 
regulate BMSC structure, hence its phenotype specifically towards the valvular lineage.  
In this investigation, we are going to apply OSS to growing valvular endothelial cells and 
BMSCs to understand their structural changes to this environment, which would 
subsequently have implications to the underlying cellular basis for restenosis and for 
optimizing heart valve tissue engineering protocols, respectively 
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SPECIFIC AIMS 
Specific Aim 1: To compare changes in the hemodynamic environment after balloon 
valvulplasty compared to a normal patient using a computational fluid dynamic model 
(ANSYS CFD).  
Specific Aim 2:  To observe changes on F-actin and nuclear deformation on bone 
marrow stem cells when exposed to pulsatile flow, steady flow, and no flow 
environments.  
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CHAPTER II- LITERATURE REVIEW 
Composition of the Aortic Heart Valve and Function 
The aortic heart valve is composed of three leaflets, which open and close during systole 
and diastole respectively. Over a single lifetime, hear valves will open and close at least 
3x109 times (sacks 2015, heart valve function). The tissue and cells that constitute the 
leaflets must have unique characteristics that allow them to open and close properly, as 
well as remodel as needed4. The leaflets are comprise of three different layers, which 
include the fibrosa (facing the artery), ventricularis (facing the ventricle), and the 
spongiosa, which is located between the fibrosa and the ventricularis, each containing 
different cells and molecules and each experiencing different fluid flow profiles7,12 
(Figure 1). The ventricularis surface is exposed to a high velocities and unidirectional 
shear stress, while the fibrosa side undergoes through OSS and lower velocities13. The 
ventricularis side is composed of elastin, which is radially aligned, and collagen, with an 
isotropic alignment. On the other hand, the fibrosa is longitudinally aligned collagen 
fibers. The spongiosa, consists with glycosaminoglycan and proteoglycan, create a shear 
slip buffer zone during leaflet movement12. These three layers provides the tensile 
strength the valves need in order to resist the mechanical forces being exerted14.The 
leaflets composition and structure allow them to endure demanding mechanical forces as 
they function under a complex of cyclic tensile-flexure-shear stress, such as oscillatory 
shear stress (OSS), loading environment3,14. During the cardiac cycle the heart pumps 
about 3-5 liters of blood every minute through the valves 15 which results in transvalvular 
pressures of 10mmHg in the pulmonary valve and 80mmHg in the aortic valve, as well as 
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shear stress estimated values of 10-80dynes/cm²  on the aortic valve16. The aortic valve, 
needing to withstand very demanding and complex mechanical stress, makes it difficult 
for prosthesis to endure without causing health risks on the patient.  
 
 
 
  
 
 
Valvular Endothelial Cells (VECs)  
The leaflets are also composed of valvular endothelial cells (VECs) and of valvular 
interstitial cells (VICs).  Endothelial cells, lining most of the organs, carry many critical 
function for blood and tissue homeostasis3. There are three main roles carried out by 
valvular endothelial cells: regulation of coagulation, regulation of underlying interstitial 
cells, and the diffusion or clearance of threatening agents from the blood3. It is well 
established that the endothelial cells are the first responders to tissue damage, controlling 
coagulative response to ensure clotting during injury. VECs have also shown to express 
von Willebrand factor, a blood glycoprotein involved in homeostasis, and also modulate 
the expression of factors involved in coagulation in response to shear stress3. However 
Figure 1. Heart valve composition showing fibrosa, 
spongiosa, and ventricularis. (Wirrig, 2013) 
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the dysfunction of VECs can result in many clinical conditions such as inflammatory 
reactions, calcification and blood clots17.  
As stated previously, shear stress is one of the main mechanical stresses found in blood 
vessels and heart valves. Butcher et al. has previously shown that there are morphological 
and behavioral differences between VECs and aortic endothelial cells due to the different 
biomechanical environments they are exposed to2. Several groups have studied the effect 
of shear stress on endothelial cells, and have demonstrated that VECs respond differently 
by orienting perpendicular to flow and parallel to the circumferentially aligned 
underlying tissue3; whereas vascular endothelial cells align parallel to flow regardless 
matrix orientation18. VECs do not only show phenotypic differences from vascular 
endothelial cells, they also express different genes as a response to fluid induced shear 
stress. Aortic endothelial cells show an increase expression of proinflammatory genes 
such as interlukins, connexin 43, BMP-4, and Collagen type II, all of which have been 
shown to contribute to vascular endothelial cell inflammatory atherosclerosis. On the 
other hand, VECs have shown a more abundant expression of anti-inflammatory genes 
and a less abundant expression of pro-inflammatory genes, suggesting that VECs may be 
innately more anti-inflammatory than aortic endothelial cells19. Previous studies have 
also shown that VECs are more proliferative than aortic endothelial cells20.  
One of endothelial cells unique characteristics is the ability to change from VECs to a 
contractile myofibroblast-like VICs, a process called endothelial-mesenchymal 
transformation (EMT)21. EMT has been shown to begin with endothelial cells losing cell-
cell contact and separating from the monolayer. Subsequently losing endothelial markers 
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and gaining mesenchymal markers, and migrating to the interstitial space22.  
Balachandran et al reported to induce endothelial cells to undergo EMT by applying a 
pathological cyclic strain, suggesting that mechanical strain does regulate EMT in a 
directionally dependent manner21.The role of EMT in the adult heart valve is not well 
known, however it is a critical event for embryonic development of the heart valve23 
(Figure 2). 
 
Valvular Interstitial Cells (VICs) 
VICs are the most prevalent cell in the heart valve and are found in all three layers of the 
valve24. The interstitial cells are made up of fibroblasts, smooth muscle cells, and 
myofibroblast which share the characteristics as smooth muscle cells and fibroblasts25. 
VICs main function is to maintain the structural integrity of the leaflets by constantly 
remodeling the tissue and by secreting matrix metalloproteinases. The dualistic mode for 
VICs is not well understood, however it is thought that the phenotype associated with 
smooth muscle actin is involved in proliferation and migration. Furthermore, the 
Figure 2. EMT process during heart valve formation. Endothelial cells going through                                                     
EMT  and migrating into the interstitial space (cardiac jelly) (Bischoff, 2007) 
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contractile phenotype found on these cells is associated with the remodeling of the 
extracellular matrix26.  In vivo studies have suggested that VICs produce high amount of 
proteins and glycosaminoglycans17.  
It has been established that pulsatile hemodynamic shear stress, which found in the heart 
valve, affects VICs through VECs as well as through other pathways including matrix 
shear stress24. When VICs are applied a mechanical force they respond by altering 
cellular stiffness and by producing matrix component24. Recent studies have shown 
collagen production of VICs after being subjected to stretching forces, however the type 
of collagen being produced was dependent on the level of the stretch. Collagen III gene 
expression increased as the level of stretch increased as well24. Mechanical stresses, 
sensed initially by VECs, are transduced by same to regulate VICs through paracrine 
signaling. VECs also stimulate a decrease in VICs proliferation, an increase in protein 
synthesis with shear stress, and a reduction of glycosaminoglycan loss under flow24. 
Aortic Heart Valve Hemodynamics 
The hemodynamic environment surrounding the heart valve, controls and ensures its 
proper functionality. The heart valves, as previously mentioned, are exposed to different 
mechanical stresses including, high levels of cyclic flexure, stretch and fluid-induced, 
oscillatory shear stresses (OSS). Wall shear stress (WSS) is considered the most 
important hemodynamic parameter for endothelial cells, defined by the following 
equation: Tw= 4µQ/πR³. Q is the volume flow rate, µis the viscosity and R is the radius 
of the vessel. In blood vessels, the mean wall shear stress reported is believed to be 10-20 
dynes/cm². However, WSS on the heart valves are difficult to obtain, and several groups 
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have reported figures ranging from 20 dynes/cm² to 1000 dynes/cm² 3.In healthy heart 
valves, the peak blood velocity, occurring at peak systole, on the aortic heart valve has 
been shown to be 1.35± 0.35ms-1 27. However, due to the fact that each side of the leaflet 
experience different velocity gradients, we would expect them experiencing different 
shear stresses as well. The fibrosa side of the leaflet undergoes pulsatile unidirectional 
shear stress, and the ventricularis undergoes oscillatory shear stress (OSS) caused by 
vortices present on this side of the leaflet. These vortices are thought to facilitate the 
movement of the leaflets to a close position during diastole25. 
In addition to WSS, we have other mechanical components affecting the heart valves: 
flexure and stretch.  Valvular leaflets are stained in a biaxial pattern, having peak 
circumferential trains of approximately 10% and radial strain of more than 40%.28,29. 
When opening, leaflets also experience a high degree of flexure, resulting in a 
compressive strain in the fibrosa side and a tensile strain in the ventricularis side 30. Thus, 
the fibrosa and the ventricularis undergo different mechanical stress patterns which could 
affect the behavior of the endothelial and interstitial cells. However due to the 
composition of the heart valves, they are able to withstand high mechanical stresses. 
Heart Valve Disease 
Heart valve diseases include, heart valve regurgitation, stenosis, and atresia. 
Regurgitation occurs when the valve doesn’t close tightly causing blood to flow back into 
the ventricle. Atresia consists of lacking an orifice or having the orifice abnormally 
closed, preventing blood to pass through. In the case of stenosis, which is the most 
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common condition in heart valve disease, involves the thickening and hardening of the 
heart valve preventing the valve to fully open during the cardiac cycle (Figure 3).        
 
 
 
 
 
 
 
There are people who are born with this condition, congenital heart valve stenosis, 
whereas other people develop AVS through their lifetime. Aortic valve stenosis (AVS) 
was considered a “wear and tear” degenerative conditions which resulted in the formation 
of calcium deposits in the heart valves. However, new evidence have shown that AVS 
can be developed as part of a complex, regulated series of processes similar to 
atherosclerosis31.  As in atherosclerosis, the damaging of the endothelial layer due to an 
increase in mechanical stresses, is thought to be the initial event for developing AVS. 
Following endothelial injury, the same lipids involved in atherosclerosis, are shown to be 
involved in heart valve calcification, in particular oxidized low-density lipoprotein 
cholesterol (LDL) and lipoprotein A32. The lipid oxidation then establishes an 
inflammatory response by recruiting macrophages, T lymphocytes and mast cells32. At 
Figure 3. The composition of a normal heart valve and a stenotic 
heart valve (USC, 2012). 
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this stage, studies have shown the initiation of calcium deposition in the area of injury, 
which has been associated with cell death. Apoptotic bodies have demonstrated to have 
similar characteristics as matrix vesicles found in bone32. Thus the formation of aortic 
stenosis has been associated with inflammation and lipid deposition. 
Endothelial damage can be caused by several factors, including abnormal hemodynamics 
and tissue mechanics 3. It has been previously shown VECs undergoing physiological 
shear tress values, respond by expressing anti-inflammatory genes, however when they 
are exposed to abnormal fluid flow shear stress there was an activation of inflammatory 
mediators33.  Studies have also shown the activation of calcification genes, chondrogenic 
genes, after VECs have been exposed to abnormal shear stresses33. Besides inducing the 
cells to express calcific genes through shear stress, other studies have also shown an 
increase in calcific gene expression when VECs are exposed to high levels of strain, 
another innate mechanical force found in heart valves.   
Yoganthan et al. has previously shown an even distribution of flow field during peak 
systole on a normal heart valve with maximum velocity of 1.2 ms-1, while a jet-type flow 
field with maximum velocity of 7.0 ms-1 was observed in a stenotic valve34. In the 
stenotic heart valve, Yoganthan also observed a high turbulent shear layer around the 
heart valve which could cause damage to the blood elements and the endothelial cells 
lining the valve and the walls34.  
Heart Valve Tissue Engineering 
The replacement of the diseased heart valve, is not a common procedure done in order to 
enhance the survival and quality of life of the patients. Current mechanical and 
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bioprosthetic heart valves give the patient 15-20 years of adequate function in adults3. 
However, the mechanical heart valves are prone to inflammation, infection and 
thrombosis, while the bioprosthetic heart valves experience calcification on the valve 
cusps, leading to regurgitation and reduced orifice area 35. Furthermore, in the pediatrics 
application, reoperation are required in order to accommodate larger valve diameters as 
they grow older.  Tissue engineered heart valve (TEHV) has a great potential to generate 
suitable viable heart valve replacement, and overcome the risks associated with 
mechanical and bioprosthetic heart valves. The ideal heart valve is characterized as a 
non-thrombogenic, viable living tissue that lasts the lifetime of the patient, providing 
remodeling and repair of injuries and potentially allows somatic growth25.  
The approach that most groups are implementing is the seeding of cells into a 
biodegradable scaffold, and culturing the construct under appropriate environmental cues 
to induce tissue formation, and then implanting these pre-conditioned constructs in 
vivo35. Hoerstrup et al.  pre-conditioned the construct using a pulsatile flow bioreactor 
device and implanted the constructs into six lambs36. Through echocardiogram, the 
leaflets were shown to function correctly without stenosis, thrombus or aneurysm up to 
20 weeks. They also revealed a layer of cuspal tissue with collagen and elastin, and 
covered by endothelium.  Other groups have been using mesenchymal stem cells and the 
biodegradable scaffold PGLA/PGA for TEHV. Mesenchymal stem cells, due to their 
accessibility, self-renewal properties, and phenotypic plasticity under biochemical and 
mechanical stimulation, are a promising cell source for tissue engineering. Sutherland et 
al. has previously used ovine bone marrow stem cells to construct an autologous 
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semilunar heart valve, which showed deposition of extracellular matrix and distribution 
cell phenotypes reminiscent of that in a native pulmonary heart valve, after implantation 
in a sheep37.  We have previously created a construct using PGA/PLLA and BMSCs 
cultured under flex-flow conditions in a bioreactor. We observed BMSC differentiation 
and migration within the engineered tissue, leading to cells expressing endothelial 
markers lining the surface, and cells expressing myofibroblast-markers within the tissue, 
resembling the cell distribution in a native heart valve.  
These advances can help us understand the multiscale hierarchical arrangements typically 
found in heart valves, and therefore develop viable tissue engineered heart valves.   
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CHAPTER III: STEM CELL STRUCTURAL ADAPTATION TO FLOW: 
IMPLICATIONS FOR VALVULOGENESIS 
Bone marrow stem cells (BMSCs) have been implicated in the development of heart 
valve tissue engineering. OSS, a mechanical force present in heart valves, has been 
shown to differentiate BMSCs into a cell showing endothelial cells markers. 
Furthermore, OSS coupled with flexure has shown an increase of valvular endothelial 
cells markers on BMSCs suggesting a potential differentiation of these cells. The 
differentiation of stem cells has been linked to changes in actin filaments, causing a 
change in gene expression. We previously observed the effects of oscillatory shear stress 
(OSS) on the BMSC cytoskeleton after terminal chemical fixation of the cells. The 
alterations in BMSC cytoskeleton during OSS has not yet been understood. Thus, in this 
study we applied OSS to growing BMSCs to understand fundamental cellular structural 
responses that precede the resulting gene expression, in the context of the heart valve 
phenotype. By identifying these changes a deeper understanding of specific changes at 
the cell structural-level, could be achieved and potentially fine tune the flow conditions to 
achieve an optimized valvular phenotype. 
 
INTRODUCTION 
Critical valvular heart disease is a serious cardiovascular complication38. In infants, 
congenital heart defects occur in four to six infants for every 1000 births39. 
Approximately 24.5% of neonatal mortality is attributed to congenital heart defects40.   
Among the plethora of cardiovascular defects, one of the more common, yet life-
threatening conditions is critical aortic valve stenosis (AVS),  which results in high 
mortality and morbidity despite early intervention41. Under normal circumstances, valve 
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leaflet composition and structure permits endurance of demanding mechanical forces as 
they function under a complex, coupled loading state of cyclic tensile, cyclic flexure-and 
fluid-induced shear stresses, including oscillatory shear stresses (OSS)2. However, in 
AVS, significant systolic transvalvular pressure gradients with a mean > 60mmHg 
resulting from narrowing of the aortic root imposes considerable workload on the left 
ventricle, resulting in rapid heart failure if left untreated17,35,42.  Intervention to relieve 
aortic valve stenosis in the neonate is usually approached via balloon dilation of the aortic 
valve, performed through an interventional cardiac catheterization (balloon aortic 
valvuloplasty/BAV).   Although the short term results are beneficial usually leading to 
relief of the narrowed structure and temporary avoidance of the consequent left 
ventricular failure, mid to long term prognosis is variable41.  Moreover, sizing limitations, 
risks associated with anti-coagulant use in children, accelerated calcification and an 
inability to accommodate somatic growth severely limit use of commercially available 
prosthetic valves for replacement of the infant’s stenosed valve. 
Over the last ten years, tissue engineered heart valves (TEHVs) derived from stem cells 
have been investigated to overcome the shortcomings associated with treatment of critical 
valve anomalies in children. Recent studies have applied mechanical stimuli, to construct 
superior tissue structures with properties resembling native heart valves, in particular, 
using bone marrow-derived stem cells (BMSCs) seeded onto biodegradable scaffolds11,37. 
BMSCs are a promising cell source due to their accessibility, self-renewal properties, and 
phenotypic plasticity under biochemical and mechanical stimulation. Stem cell 
differentiation using growth factors, molecular inhibitors, and biochemical cues have 
been extensively studied, however the mechanotransduction regulatory pathways in stem 
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cell differentiation remains uncertain43. Mechanical loads have shown to play an 
important role in the development, growth, and maintenance of tissue functions, such as 
the remodeling of cardiovascular tissues and bone formation44. Recent studies have 
demonstrated that fluid-induced shear stresses can regulate mesenchymal stem cell 
migration and stimulate stem cell differentiation into different cell lineages, including 
osteoblasts and endothelial cells (ECs)45. However, the effect of mechanical forces in the 
context of stem cells used in heart valve tissue engineering, where the mechanics play a 
foundational role, is yet to be delineated. Nonetheless, a few pertinent, landmark studies 
are summarized as follows: It was previously demonstrated that coupled flexure and flow 
environments augmented tissue formation using PGA:PLLA scaffolds seeded with 
BMSCs11. Elsewhere, Sutherland et al utilized BMSCs isolated from ovine and 
PGLA/PGA biodegradable scaffolds to make autologous semilunar heart valves, which 
were later implanted in sheep, and subsequently showed extracellular matrix and 
distribution of cells in the engineered valve were similar to native heart valves37. 
However, structural differences such as the absence of surface ridges in TEHVs were 
evident and were thought to potentially result in early failure of these constructs11.  
Mechanical stimuli are sensed by the cell membrane receptors which are later transferred 
to the cytoskeleton; consequently this initiates a biochemical signaling cascade 19. In 
BMSCs, the cytoskeletal structure has shown to be altered after exposure to fluid-induced 
shear stress46. Fundamental changes in actin structure and distribution may thus closely 
be linked to gene expression and protein synthesis in the shear stress stimulation of stem 
cells3, similar to ECs47. The actin filaments of the cell cytoskeleton serve as structural 
contributors to modulation of subsequent cell biological responses, including gene 
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expression, cellular and matrix protein synthesis. In general, it has been shown that the 
application of mechanical stress on actin filaments causes cytoskeleton reorganization 
leading to tissue remodeling affecting stem cell viability, self-renewal, and 
differentiation48, although detailed characterization of intracellular structures specifically 
in response to fluid-induced shear stress is not known. In addition, other cellular 
components such as focal adhesions, integrins, and the nucleus collectively play 
important roles in modulating cellular biological responses37. For example, the 
connection between the matrix and the cytoskeleton allows the cell to transmit external 
forces to the cell’s nucleus, thus triggering biochemical signals such as the synthesis of 
signaling proteins49.   
We previously observed the effects of oscillatory shear stress (OSS) on the BMSC 
cytoskeleton after terminal chemical fixation of the cells50. OSS regulates BMSC 
structure and has been shown to be highly relevant to native heart valve development and 
to TEHVs51. However, as was previously stated, the fluid-induced, OSS-related structural 
changes that precede BMSC phenotypic switching and matrix production are not known. 
Yet, identifying alterations in the BMSC cytoskeleton during OSS exposure may lead to a 
deeper understanding of specific changes at the cell structural-level, that lead to 
differential regulation, which in turn can be used to fine tune the flow conditions to 
achieve an optimized valvular phenotype.  Thus, in this investigation we applied OSS to 
growing BMSCs to understand fundamental cellular structural responses that precede the 
resulting gene expression, in the context of the heart valve phenotype.  These efforts are 
novel and unusual in that OSS is a relatively lesser known mechanical stimulus which to 
our knowledge has never been applied in order to identify the structural responses of 
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BMSCs; yet such a study is highly relevant to heart valve tissue engineering 
developments. 
METHODS 
Culture and Expansion of BMSCs 
Approximately 5x105 BMSCs/mL (Fisher Scientific, Pittsburgh, PA) were cultured in 
T75 vented cell culture flask using AdvanceStem Mesenchymal Stem Cell Medium (GE 
Healthcare Hyclone, Logan, UT) with 10% mesenchymal stem cell growth supplement 
(GE Healthcare, Malborough, MA)  and 1% penicillin and streptomycin (Fisher 
Scientific, Waltham, CA) for growth and expansion. Cells were grown in a standard cell 
culture incubator operating with 5% CO2 at 37°C with 95% humidity. BMSCs culture 
expanded to passages 4 to 6 were utilized for subsequent studies.  
BMSC Transfection 
BMSCs were transfected for purposes of cell visualization with green fluorescent protein 
(GFP) via electroporation as previously described52.  In brief, a density of 1x106 BMSCs 
were transfected using electroporation (Gene Pulser Xcell Electroporation System BIO-
RAD, Hercules, CA) and plasmid-delivery of 60µg pTAGGFP-actin, a vector encoding 
TagGFP fusion with actin used for labeling actin filaments in living cells (Evrogen, 
Moscow, Russia). The following settings were used for electroporation: Exponential 
Decay Pulse, Voltage of 350 V, capacitance of 950 uF, and Resistance: of 200 ohms52. 
Transfection Efficiency 
Cell viability and cell apoptosis was assessed using propidium iodide (PI) solution and 
Annexin protein respectively following manufacturer supplied instructions (Biolegend, 
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San Diego, CA). In brief, two days following transfection, BMSCs were re-suspended in 
Annexin V Binding Buffer at a concentration of 2.5x 105 cells/ml. PI was added to 100µL 
of cell suspension. After 15 min of incubation without light exposure, they were 
evaluated by flow cytometry (BD Bioscientific, San Jose, CA). 
Fluid-Induced Mechanobiology Experiments 
Transfected BMSCs were plated in Collagen Type I (Fisher Scientific) coated 
microchannels. A square wave was used in order to create a pulsatile flow environment to 
which the cells were going to be exposed to using a shear stress cell assay system 
(Fluxion Biosciences, South San Francisco, CA). Images of the cells under no flow, 
steady flow and OSS environments were acquired using fluorescent microscopy 
(Olympus IX81, CA) every hour for 5 hours for the first 2 days. After the second day, 
cells were monitored every 24 hours.  Cells in the no flow, steady-state (SS) flow and 
OSS groups were cultured for a total of 3 days.   
Cell Structure Quantification  
Cell actin filaments and nucleus were quantified by analyses of images acquired during 
the time course of the cell culture experiments (ImageJ, NIH Image, Bethesda, MD). 
Actin filament quantification was performed using two metrics. The initial quantification 
was based on simple filament counting.  For the second metric, the actin filament 
distribution and deformation were observed.  Quantification of the cell nucleus was 
conducted by computing the nuclear eccentricity parameter. Nuclear eccentricity 
(circularity) is a measure of nuclear elongation and is in a range of [0,1]; a circle has an 
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eccentricity of 1 whereas a more elongated shape would be associated with a lower 
number (ImageJ). 
Statistical Analysis 
One-way Anova followed by a Tukey’s post hoc test was conducted to test for any 
significant differences between the three groups: no flow, SS and OSS (n=8 wells/group; 
SPSS, V16, IBM, Armonk, NY). A statistically significant result was interpreted to have 
occurred when p < 0.05.  
RESULTS 
Transfection Efficiency 
GFP Transfection was initially found to occur in 77.4% of the cells.  (Figure 4). However 
of all the cells utilized, eventually ∼50% of the cells were found to be both viable and 
Figure 4. Transfected BMSCs with actin GFP were assessed two days 
after electroporation using flow cytometry; 77.43% of the cells were 
shown to express high GFP intensity as seen in the first quadrant. 
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successfully transfected (Figure 5). Viable transfected were subsequently segregated from 
the general population for use in subsequent experiment. 
 
Number of Actin filaments 
BMSC actin filaments increased in number by 122.6% after 48 hours of OSS (Figure 6). 
On the other hand, cells exposed to SS demonstrated only an 18.2% increase in the 
average number of filaments/cell after 48 hours of exposure, while the no flow group 
displayed a marginal changes.  The average increase in the number of filaments in cells 
exposed to OSS compared to both SS and no flow groups was found to be significant (p < 
0.05). However, there was no significant difference in comparing the average number of 
filaments/cell between cells exposed to SS and no flow (p > 0.05). 
Figure 5.  Transfected BMSCs with actin GFP assessed two days after 
transfection were incubated in propidium iodide (PI) solution to evaluate 
cellular viability;  50.07% of cells were efficiently transfected and viable 
after electroporation, as seen in 
23 
 
 
Figure 7. OSS, SS, and No Flow (static) conditions on average BMSC actin 
filament length (n=8 wells/group). 
Figure 6.The effect of BMSC when exposed to OSS, SS, and No 
Flow (static) conditions on the number of actin filaments (n=8 
wells/group). 
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F-actin filament length  
There was a 53.8% decrease in the average length of the filaments after 48 hours in the 
cells exposed to OSS (Figure 7). On the other hand, there was a 19.5% increase in 
average filament length on cells exposed to SS and marginal changes in cells in the no 
flow group. A significant decrease in the average actin filament length (p <0.05) in 
BMSCs exposed to OSS compared to cells in both the SS and no flow groups was 
observed.  
Nuclear Eccentricity 
We observed noticeable short term changes in nuclear shape in the SS and OSS groups 
during the first five hours after treatment compared to the no flow controls (Figure 8). 
However, after 48 hours, nuclear eccentricity was found to return to its original 
configuration and was not found to be significantly different amongst the no flow, SS and 
OSS groups (p < 0.05).  
Figure 8. Nuclear eccentricity (circularity) in BMSCs while being exposed to OSS, SS, 
and No Flow (static) conditions (n=8 wells/group). 
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Figure 10. Transfected cells showing filament orientation at 0 and 48 hours. SS group. 
Figure 9. Transfected cells showing filament orientation under OSS. 
Figure 11. Transfected BMSCs imaged at No Flow (static) conditions at 0 hours 
and at 48hours. Yellow arrows point to the actin filaments and red arrows show 
the nucleus 
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DISCUSSION 
Pediatric patients suffering from congenital aortic valve anomalies such as a critical 
valvular stenosis have extremely limited treatment options.  Balloon aortic valvuloplasty 
is typically performed longitudinally to relieve the narrowing and eventually the patient 
may undergo a total valvular replacement with a prosthetic device. Unlike prosthetic 
heart valves, TEHVs offer the possibility of overcoming the risks associated with 
artificial valve replacement in children and by offering the potential to support somatic 
growth. BMSCs remain a promising cell source because they promote tissue repair and 
can differentiate along cardiovascular and valvular pathways. Biochemical environments 
play a key role in determining cell fate and the differentiation of BMSCs. However, 
recent studies that have applied mechanical stimuli to BMSCs clearly demonstrate that 
the resulting cellular cues regulate proliferation and cell differentiation events; 
chondrogenic, endothelial, as well as cardiomyocyte phenotypes have been observed 15.   
BMSCs have been exposed to different mechanical stress states, such as tension, 
compression, and fluid-induced shear stress7. The application of tensile strain has been 
shown to result in an increased gene expression of bone markers, such as Runx2, alkaline 
phosphate (ALP), collagen type I (Col1), and bone morphogenic proteins (BMPs) 7. 
Recent studies have also shown the effect of mechanical stretch on the differentiation of 
stem cells, resulting in an increase in ALP activity and extracellular matrix formation as 
well as phosphorylation of focal adhesion kinase (FAK)13.  A fundamental response to 
mechanical stimuli can thus be observed within the cell cytoskeletal structure.  For 
example, McBeath et al. demonstrated that mechanical signals influence stem cell fate 
through linkages between cell shape, cytoskeletal mechanics, and protein activation20. 
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They disrupted the actin cytoskeleton using an actin-disrupting agent, cytochalastin D, 
and were able to observe differentiation of stem cells towards adipocytes, rather than 
osteocytes, suggesting a vital role of the cytoskeleton in the differentiation of stem cells 
towards an osteoblast lineage.  Similar to tensile strain, fluid induced shear stress has also 
been shown to regulate osteogenic genes in BMSCs5. Specifically, upon exposure of 
BMSCs to OSS, cells demonstrated an increase in calcium mobilization, and an increase 
in expression of osteocalcin and osteopontin18. Furthermore, exposure of BMSCs to OSS 
also increased DNA methylation, a central cellular mechanism for modulating gene 
expression.  We subsequently wanted to identify fundamental changes in BMSC structure 
to OSS as a precursor to cellular signaling activity and eventual gene expression.  A 
priori knowledge of BMSC structural events leading to the valvular phenotype may be 
leveraged to optimize engineered heart valve tissues intended for subsequent animal 
studies or clinical translation.  Such optimization is important in the context of enhancing 
mechanical and biological resilience of the engineered construct when subjected to the in 
vivo environment. 
OSS is an innate mechanical state present on the surfaces of native heart valves and has 
been hypothesized to enhance valve coaptation26. We previously demonstrated that the 
actin filaments in BMSCs orient themselves parallel to the flow direction when exposed 
to OSS23. In this study we applied a mean OSS of 1 dyne/cm2 and observed the changes 
in actin filaments and the nucleus over 48 hours. The BMSCs exposed to OSS and SS 
were found to orient themselves in the direction of flow (Figure 10, Figure 11) which is 
not unlike ECs which also orient themselves in this manner4.  Moreover, we found a 
significant increase (p<0.05) in the average number of actin filaments (Figure 6) in 
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BMSCs while being exposed to OSS (48 hours), which we speculate, could be a result of 
augmented focal adhesions (FAs). FAs play an important role in the force-mediated 
differentiation of stem cells 28. At the same time it has been reported that the formation of 
FAs is rapidly activated by specific forces exerted on cells, thereby resulting in the 
generation of additional actin filaments 28, which is indicative of what we observed here 
for the BMSCs exposed to OSS.  This finding therefore suggests that OSS may serve as a 
more appropriate trigger of stem cell differentiation compared to uni-directional shear 
stress.  In particular, OSS may promote BMSC differentiation towards the cardiovascular 
and valvular cell types as it is blood or fluid-induced and therefore highly relevant to 
these phenotypes. We also observed a significant difference (p<0.05) in the average 
length of actin filaments between the OSS and SS groups (Figure 7).  We speculate that 
the dramatic decrease in the length of actin filaments in BMSCs exposed to OSS could be 
a result of the activation of cofilin, an actin-binding protein which disassembles actin 
filaments 23. The context of this process is the similar response of endothelial cells to 
fluid shear stress that results in dissociation of actin filaments, thereby permitting cellular 
alignment to flow 23.  Therefore, we speculate that a decrease in actin filament length 
under OSS states to be a triggering event for mesenchymal to endothelial transformation, 
an important process in promotion of an endothelium in the tissue engineered heart valve.  
We have previously demonstrated that in fact, OSS states do augment the endothelial 
phenotype in in vitro dynamically cultured engineered valvular tissues 24 .  Note that SS 
conditions resulted in an increase in filament length (Figure 7) which may indicate 
reduced actin disassembly and hence, more restrictive differential regulation of BMSCs 
compared to OSS. 
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In conclusion, we presented the changes in F-actin filaments and nuclear deformation 
responses of BMSCs to OSS, SS and no flow conditions over a period of 48 hours. 
Structural changes and differences were clearly observed between the groups. 
Specifically, OSS-conditioned cells responded with a substantial increase in the number 
of actin filaments but a considerable decrease in the length of the filaments.  These events 
could serve as structural precursors that may differentially regulate BMSCs towards a 
valvular phenotype.  On the other hand, we did not observe a significant difference in the 
nuclear shape among the OSS, SS and no flow groups; however further studies need to be 
conducted to determine the effects of fluid-induced nuclear deformation on BMSC 
differentiation.  Even though our results are preliminary, our study provides a simple, yet 
unique perspective on specific cytoskeletal changes, particularly under OSS states that 
could regulate stem cell fate in a manner conducive for engineering valvular tissues.  
Nonetheless, further studies will be needed to confirm a direct correlation between the 
cytoskeletal changes observed here to the differentiation and gene expression activity of 
BMSCs. 
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CHAPTER IV: OBSERVING CHANGES IN HEMODYNAMICS OF A HEALTHY 
HEART VALVE AND A TREATED HEART VALVE USING A COMPUTATIONAL 
MODEL 
INTRODUCTION 
Congenital heart defects are the most common birth defects, with about 1% of the 
population being affected by them4. One of the most severe being critical aortic valve 
stenosis (AVS), a life-threatening condition with high morbidity despite early 
intervention. In AVS, significant systolic transvalvular pressure gradients with a mean > 
60mmHg resulting from narrowing of the aortic root imposes considerable workload on 
the left ventricle, resulting in rapid heart failure if left untreated3,35,42 . Open surgical 
valvotomy and a less invasive procedure, transcatheter balloon valvuloplasty of the aortic 
valve, are two of the most used and recognized procedures done in neonates with AVS. 
Balloon valvuloplasty has been shown to reduce the pressure gradient across the aortic 
valve around 60%6. Even though this procedure has shown promising results, 
reintervention following aortic balloon valvuloplasty is high due to several factors, 
including restenosis in one third of the patients6. Recent studies have shown that in 
vascular endothelial cells, flow patterns are critical in the sense that they influence the 
initiation of atherosclerosis, in-stent restenosis, and bypass graft failure6. After balloon 
valvuloplasty, there is a relief in the pressure gradient across the aortic valve, however 
the hemodynamics do not resemble that of a normal valve, which could play an important 
role in the cause of restenosis. Valvular leaflet remodeling has been traced to endothelial 
cell dysfunction and denudation2, which is the primary suspect for the cause of restenosis 
in patients with balloon valvuloplasty. Valvular endothelial cells, like vascular 
31 
 
endothelial cells, are known to remodel in response to hemodynamic environments by 
sensing the mechanical signals, and reorganizing the cytoskeletal filaments and the focal 
adhesion complexes, therefore altering gene expression2. By evaluating the changes in 
hemodynamics following balloon intervention, we can delineate the potential primary 
precursor which could be linked to underlying cause of rapid restenosis after balloon 
implantation.  
METHODS 
Isolation of porcine valvular endothelial cells (VECs) 
Side specific porcine valvular endothelial cells were isolated as previously described in 
Gould, et.al 201053. In brief, porcine heart valves were dissected and valvular endothelial 
cells from the ventricularis side and fibrosa side were dislodge using collagenase type II 
(Worthington Biochemicals, Lakewood, NJ). After isolation, cells were grown for 3 days 
for them to recover from the harsh process.  
Immunostaining VECs 
Isolated VECs were plated in pre-coated slides with collagen (BD Biosciences, Franklin 
Lakes, NJ). The following procedure was followed for subsequent staining: Isolated cells 
were cultured to ~80% confluence and fixed with 4% formaldehyde. Fixed cells were 
permeabilized with 0.1%TritonX-100 for 5 min (this step was excluded for CD31 
staining). Additional washing steps were performed three times with DPBS. Blocking 
nonspecific epitopes was facilitated by adding 3% BSA in DPBS for 30 min. The primary 
antibodies used were rabbit polyclonal anti-smooth muscle actin (Abcan, Cambridge, 
MA) and goat polyclonal anti-CD31 (Abcan, Cambridge, MA). An overnight incubation 
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at 4° was done. Samples were later washed and the second antibody was added for 1 
hours at room temperature. Fixed cells were later viewed under a fluorescent microscope 
(Olympus BX51, Center Valley, PA). 
Computational Fluid Dynamics 
In order to extract the shear stress waveforms, we conducted a CDF (Ansys Canonsburg, 
PA) simulation depicting the aortic structure from the normal patient and the patient who 
underwent balloon valvuloplasty. The geometry consisted of a 3D (x, y, and z 
dimensions) structured mesh with 1.5million nodes. However analysis will be done along 
the 2D plane from which the geometry was built because the cross-section of the valve 
and artery geometry was not available from medical images.  The measurements for each 
patient were obtained from JDCH through a sonogram (Figure 12, Figure 13). The 
velocity profile was fed to the inlet and the pressure profile was inputted to the output 
(Figure 14, Figure 15, Figure 16, and Figure 17). A transient simulation was used, 
placing the convergence criteria to 1x10-6 for momentum and continuity, with time steps 
Figure 12. Echocardiography flow profiles from normal 
patient obtained from JDCH. 
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of 0.1s. Blood properties were used in order to run the model.  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 13. Velocity profile from a normal fed to the inlet in the simulation (Ansys 
CFD). 
Figure 14. Echocardiography flow profiles from patient 
after balloon valvuloplasty obtained from JDCH 
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Figure 15. Pressure profile from a normal patient fed to the outlet in the simulation 
(Ansys CFD). 
Figure 16. Velocity profile from a patient after balloon valvuloplasty fed to the inlet in 
the simulation (Ansys CFD) 
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RESULTS 
Model Validation 
In order to validate our model, the transvalvular pressure gradient from our model was 
compared to the transvalvular pressure from the clinical data. The inlet pressure 
waveform was also measured and compared the clinical data provided by the hospital. 
For the post-balloon model, the pressure gradient calculated by our model was 
26.06mmHg, whereas the clinical was 26.00mmHg, giving a 0.23% error (Figure. 18). 
The inlet waveform calculated by the model is seen to resemble that of the clinical data 
(Figure. 19). For the normal heart valve, the transvalvular pressure calculated by the 
model was 8.20mmHg, while the clinical calculate measurement was 6.50mmHg, 
estimating a 25.15% error (Figure.20). The error observed is negated by the fact that the 
Figure 17. Pressure profile from a patient after balloon valvuloplasty fed to the outlet in 
the simulation (Ansys CFD). 
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pressure drops are relatively small. Also, due to the fact that the pressure was not 
measured directly using a catheter, clinical measurement may not be accurate, calculating 
a high error. The calculated inlet pressure was 111.75mmHg, as compared to the 
estimated value observed in clinical setting which was 120mmHg (Figure 21).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   
 
 
 
Figure 18. Transvavlular pressure gradient validation on the post-balloon 
valvuloplasty model. 
Figure 19. Inlet pressure waveform validation from treated heart valve. 
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Figure 20. Transvalvular pressure gradient validation on the normal heart valve 
model. 
Figure 21 Inlet pressure validation from a healthy heart valve. 
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Immunostaining of VECs 
VECs were stained with CD31 to check for the presence of endothelial cells and α-SMA 
to check for interstitial cells. Hoascht was used to stain the nucleus. We observe positive 
staining for CD31 (Figure 18), whereas we do not observe positive staining for α-SMA 
suggesting successful isolation of valvular endothelial cells.  
Figure 22. Isolated VECs stained positive for CD31 (Left). VECs stained negative for α-
SMA (Right). 
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Time-Averaged Wall Shear stress (TAWSS) 
There is a clear difference in the TAWSS (axial) between the normal patient and the 
patient who underwent balloon valvuloplasty on the fibrosa side. We observed peak shear 
stresses of ~2.2Pa on the leaflets of the normal patient (Figure 23). However, on the 
patient who underwent the treatment, we observed a peak wall shear stress of ~3.2Pa 
(Figure 24). Furthermore we observe a difference in the waveform between both patients.    
Figure 23. Time average wall shear stress on a normal patient. 
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Spatial-Averaged Wall Shear Stress 
The axial wall shear stress was averaged spatially throughout the heart valve for each 
time point. We observe a difference in the waveforms from the normal patient and the 
patient after the treatment on the fibrosa side. Moreover the shear spatially-averaged wall 
shear stress from the normal patient has a peak value of ~0.165 Pa (Figure 25), while 
after the treatment the peak value is observed to be ~0.45 Pa (Figure 26).  
Figure 24. Time average wall shear stress on patient after treatment 
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Figure 26. Spatially-averaged wall shear stress after balloon 
valvuloplasty. 
Figure 25. Spatially-averaged wall shear stress from the normal patient 
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Oscillatory Shear Index (OSI) 
OSI, is a measurement which quantifies the change in direction and magnitude of the 
wall shear stress (WSS), and it is calculated with the following formula: 
𝑂𝑂𝑂𝑂𝑂𝑂 = 12�1 − �∫ 𝜏𝜏𝜏𝜏𝜏𝜏𝑇𝑇0 �∫ |𝜏𝜏|𝑇𝑇0 𝜏𝜏𝜏𝜏� 
 
A Matlab code was created in order to measure the OSI throughout the valve. Side 
specific OSI was measure, fibrosa and ventricularis. We observe higher OSI in the 
fibrosa side compared to the ventricularis (Figure 27, Figure 28, Figure 29, and Figure 
30). Comparing a healthy heart valve and a valve that underwent treatment, we also 
observe a difference in the OSI. There is higher OSI in the fibrosa side of the treated 
heart valve (Figure 27, Figure 29).  
Figure 27. OSI fibrosa side of the healthy heart valve 
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Figure 29. OSI fibrosa side of a heart valve that underwent treatment. 
Figure 28.OSI ventricularis side of the healthy heart valve. 
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DISCUSSION 
Aortic valve stenosis (AVS) was considered to be caused by deterioration of the heart 
valve which resulted in the formation of calcium deposits. However, recent studies have 
shown that AVS can be developed as part of a complex series of processes similar to 
atherosclerosis. As in atherosclerosis, the damaging of the endothelial layer due to an 
increase in mechanical stresses, is thought to be the initial event for developing AVS. 
Balloon aortic valvuloplasty, a treatment usually done on teenagers and children with 
aortic valve stenosis, consists of the widening of the valve using a balloon catheter. The 
balloon is inflated in between the valve in order to increase the effective orifice area and 
improve the blood flow. This less invasive approach for aortic stenosis treatment, allows 
the pressure gradient across the heart valve to decrease (~60%), however restenosis is 
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Figure 30. OSI ventricularis side of the heart valve that underwent treatment. 
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observed soon after balloon intervention. Furthermore, flow profiles revealed by 
echocardiograms of a healthy heart valve (Figure 12) and a heart valve after treated using 
balloon valvuloplasty (Figure 13) show a difference in the velocity profiles. The peak 
velocity calculated in the heart valve that underwent treatment was 1.11m/s, while the 
peak velocity observed in the healthy heart valve was 0.66m/s. Even though this 
treatment reduces the stenosis, this difference in the hemodynamics can inherently affect 
the valvular endothelial function in a negative manner. Appropriate hemodynamics is 
important for the function of the heart valve, however changes in velocities and pressures 
can have consequences in the microscopic scales. 54 In atherosclerosis, recent studies 
have shown that the vascular endothelium is critical in the response of hemodynamic 
stimuli, and that atherosclerosis and endothelial inflammation occurs at the areas of 
disturbed flow 55. Furthermore, high shear stress gradients have also been observed to 
alter endothelial cell function by altering growth factor and cytokine production, as well 
as altering the permeability of macromolecules and lipoproteins 56. Similar to vascular 
endothelial cells, valvular endothelial cells (VECs) dysfunction is coupled with disturbed 
flow and leaflet degeneration and is also characterized by the expression of 
proinflammatory receptors57.  
Blood flow-induced shear stress is an important mechanical stimuli that is found in the 
surface of the leaflets and it is important for VECs function. VECs have been shown to 
respond to shear stress, as they change morphologically and genetically when they are 
exposed to different shear stress conditions58. Shear stress profiles present in the fibrosa 
differ from that in the ventricularis side as they are exposed to different flow profiles.  
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The ventricularis side, undergoes high shear stress values, and unidirectional flow, while 
the firbosa side experiences low shear stress values but oscillatory shear stress (OSS). 
Shear tress values in a normal heart valve from the fibrosa go up to ~0.18 Pa (Figure 25) 
and in the ventricularis values go up to ~28 Pa. Valvular pathology seems to occur 
preferentially on the fribosa side, suggesting that oscillations observed in the firbosa side 
may contribute to the calcification of the heart valves. The vortices present in the firbosa 
side help the heart valve to close more efficiently at end systole. In our model we can 
observe such oscillations, however we can see a higher magnitude of oscillations in the 
treated heart valve. In order to quantify such oscillations we calculated the OSI from both 
sides, fibrosa and ventricularis. The OSI in the ventricularis is negligible as the OSI≈0 
(Figure 28, Figure 30), however in the fibrosa side we see a higher OSI value. An even 
higher OSI distribution is observed in the heart valve which underwent balloon aortic 
valvuloplasty treatment (Figure 27, Figure 29). This finding suggests aberrant fluid 
oscillations along the arterial surface of the aortic valve that potentially may exceed 
physiologically-healthy states.  As a consequence, we interpret abnormal VEC signaling 
and tissue factor activity may be provoked, leading to restenosed states.  Confirmation of 
this hypothesis is a focus of current efforts in our laboratory, wherein arterial-side aortic 
VECs will be exposed to the aberrant levels of fluid-induced oscillations that were 
identified here.    . Studies have shown endothelial phenotypes differ on opposite sides of 
the aortic valve.58 The fibrosa side, which is more prone to lesion formation, has shown 
to express multiple inhibitor of cardiovascular calcification in a lower degree than the 
ventricularis side58. Therefore the increase in oscillations seen in the treated heart valve, 
47 
 
may cause the valve to restenosis in a more rapid manner as the fibrosa side is more 
vulnerable.  
As we could observe in our model, there is a distinct difference in the hemodynamics of a 
healthy heart valve and a heart valve that underwent balloon valvuloplasty. Changes in 
hemodynamics have been linked to endothelial dysfunction, and therefore expression of 
certain markers that may play a role in calcification. Further in vitro studies need to be 
conducted in order to observe the response of the VECs to these altered profiles, such as 
shear stress.  
. 
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CHAPTER V: FURTHER STUDIES 
As we have demonstrated, there are structural changes happening in BMSCs when 
exposed to OSS that may lead to the differentiation towards a valvular phenotype. We 
have previously shown the expression of valvular endothelial cell markers in BMSCs 
after being dynamically cultured using flex and OSS. We would like to confirm the 
correlation between the cytoskeletal changes observed to the differentiation and gene 
expression of BMSCs. Gene expression will be tested after BMSCs undergo OSS and SS 
in order to link it to the cytoskeletal changes. We clearly have shown the difference in 
averaged wall shear stress between the normal heart valve and one that has undergone 
balloon valvuloplasty. This change in hemodynamics can potentially damage the 
endothelial layer, which may lead to early calcification observed in patients that have 
been treated with balloon valvuloplasty. Here we have only shown results from the 
fibrosa side, however we would like to see the response of VECs in the ventricularis side 
as they are exposed to a higher shear stress. Changes in actin filaments and focal 
adhesions would be assessed as they have been shown to alter after being exposed to OSS 
and SS.  
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